Real-time SEC alerts Start Free →
Profitelligence
Danaher Corporation
DHR HIGH Impact

Danaher Corporation

Danaher Reports Strong Q1 2026 Earnings and Announces Masimo Acquisition

| 8-K |Healthcare

Summary

Danaher Corporation reported net earnings of $1.0 billion for the first quarter of 2026, or $1.45 per diluted common share, with non-GAAP adjusted diluted net earnings per common share growing 9.5% to $2.06. Revenues increased 3.5% year-over-year to $6.0 billion, and the company increased its full-year 2026 adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55. Additionally, Danaher announced its intention to acquire Masimo Corporation, a leading provider of pulse oximetry and patient monitoring solutions.

Profitelligence Profitelligence Alerts

Get alerts for DHR

Be first to know when Danaher Corporation files with the SEC.

Set Up Alerts →

Filing Categories

Earnings Beat General Statement M&A Transaction

Advertisement

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.

Exchange: NYSE Industry: Diagnostics & Research Company Website →

Official SEC Documents

DHR
DHR Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement